Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Xenetix 350 and Iomeron 400 for abdominal CT angiography
2006-001298-57Phase 4Completed
- Sponsor
- Guerbet
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iobitridol (2 arms), sponsored by Guerbet. Primary endpoint: Diagnostic efficacy of MSCT examination. Started Oct 2006; status: completed.
02
Drugs
iobitridol
Beyond the preview
Go deeper on 2006-001298-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001298-57.